Skip to main content
Top
Published in: Acta Neuropathologica 4/2003

01-04-2003 | Regular Paper

Clinical and neuropathological correlates of Lewy body disease

Authors: Nozomi Hishikawa, Yoshio Hashizume, Mari Yoshida, Gen Sobue

Published in: Acta Neuropathologica | Issue 4/2003

Login to get access

Abstract

We investigated distribution of neuronal and glial inclusions in 30 brains obtained at autopsy from patients with Lewy bodies (LBs) disease, which was clinically diagnosed as Parkinson's disease (PD), dementia with Lewy bodies (DLB), or pure autonomic failure (PAF). The cases were classified, according to the guidelines for the pathological diagnosis of DLB, into three types: the neocortical type, the limbic type, and the brain stem-predominant type. All postmortem brains had coil-like glial inclusions as well as LBs, and the distribution pattern and density of glial inclusions and LBs varied. The distribution of glial inclusions was strikingly similar to that of LBs. In the cerebral cortex in particular, the number of glial inclusions was fairly well correlated with the number of LBs, irrespective of the three pathological types. In the brain stem, distribution was similar between glial inclusions and LBs, and there was no distinct pathological difference among the three types. Glial inclusions and LBs were immunohistopathologically similar with respect to ubiquitin, α-synuclein, and Gallyas-Braak staining. The clinical features of the three types of LB disease were also similar; i.e., parkinsonism, some dementia, and/or autonomic failure. The inclusions in neurons and glial cells occurred in parallel with respect to tissue distribution and immunohistochemical features, suggesting that accumulation of neuronal and glial inclusions in the LB diseases have a common pathological feature. Our findings suggest that DLB, PD with and without dementia, and PAF share one clinicopathological entity.
Literature
1.
go back to reference Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239–252PubMed Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, Shinsky N, Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, Rosenthal A (2000) Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron 25:239–252PubMed
2.
go back to reference Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein. Neurosci Lett 259:83–86PubMed Arai T, Ueda K, Ikeda K, Akiyama H, Haga C, Kondo H, Kuroki N, Niizato K, Iritani S, Tsuchiya K (1999) Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein. Neurosci Lett 259:83–86PubMed
3.
go back to reference Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93–100PubMed Arima K, Ueda K, Sunohara N, Hirai S, Izumiyama Y, Tonozuka-Uehara H, Kawai M (1998) Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies. Brain Res 808:93–100PubMed
4.
go back to reference Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879–884PubMed Baba M, Nakajo S, Tu PH, Tomita T, Nakaya K, Lee VMY, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152:879–884PubMed
5.
go back to reference Braak E, Braak H (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed Braak E, Braak H (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239–259PubMed
6.
go back to reference De Vos RA, Jansen EN, Atam FC, Ravid R, Swaab DF (1995) 'Lewy body disease': clinico-pathological correlations in18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22CrossRefPubMed De Vos RA, Jansen EN, Atam FC, Ravid R, Swaab DF (1995) 'Lewy body disease': clinico-pathological correlations in18 consecutive cases of Parkinson's disease with and without dementia. Clin Neurol Neurosurg 97:13–22CrossRefPubMed
7.
go back to reference Dickson DW, Ruan D, Crystal H Mark MH, Davies P, Kress Y, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLDB) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA 2–3 neurites specific to DLBD. Neurology 41:1402–1409PubMed Dickson DW, Ruan D, Crystal H Mark MH, Davies P, Kress Y, Yen SH (1991) Hippocampal degeneration differentiates diffuse Lewy body disease (DLDB) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA 2–3 neurites specific to DLBD. Neurology 41:1402–1409PubMed
8.
go back to reference German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26:507–514PubMed German DC, Manaye K, Smith WK, Woodward DJ, Saper CB (1989) Midbrain dopaminergic cell loss in Parkinson's disease: computer visualization. Ann Neurol 26:507–514PubMed
9.
go back to reference Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27:373–385PubMed Halliday GM, Li YW, Blumbergs PC, Joh TH, Cotton RGH, Howe PRC, Blessing WW, Geffen LB (1990) Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27:373–385PubMed
10.
go back to reference Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78:194–201PubMed Hansen LA, Masliah E, Terry RD, Mirra SS (1989) A neuropathological subset of Alzheimer's disease with concomitant Lewy body disease and spongiform change. Acta Neuropathol 78:194–201PubMed
11.
go back to reference Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, Mabuchi C, Yoshida M, Sobue G (2000) Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Autonom Res 10:139–143 Hishikawa N, Hashizume Y, Hirayama M, Imamura K, Washimi Y, Koike Y, Mabuchi C, Yoshida M, Sobue G (2000) Brainstem-type Lewy body disease presenting with progressive autonomic failure and lethargy. Clin Autonom Res 10:139–143
12.
go back to reference Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol Appl Neurobiol 27:362–372PubMed Hishikawa N, Hashizume Y, Yoshida M, Sobue G (2001) Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease. Neuropathol Appl Neurobiol 27:362–372PubMed
13.
go back to reference Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMed Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMed
14.
go back to reference Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyaman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334–337PubMed Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyaman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57:334–337PubMed
15.
go back to reference Iseki E, Li F, Odawara T, Kosaka K (1997) Hippocampal pathology in diffuse Lewy body disease using ubiquitin-immunohistochemistry. J Neurol Sci 149:165–169CrossRefPubMed Iseki E, Li F, Odawara T, Kosaka K (1997) Hippocampal pathology in diffuse Lewy body disease using ubiquitin-immunohistochemistry. J Neurol Sci 149:165–169CrossRefPubMed
16.
go back to reference Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K (1999) Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 19:386–394CrossRef Iseki E, Marui W, Kosaka K, Kato M, Yamamoto T, Ueda K (1999) Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 19:386–394CrossRef
17.
go back to reference Jellinger K (1986) Overview of morphological changes in Parkinson's disease. Adv Neurol 45:1–18 Jellinger K (1986) Overview of morphological changes in Parkinson's disease. Adv Neurol 45:1–18
18.
go back to reference Kosaka K (1995) Diffuse Lewy body disease. Clin Neurol 35:1455–1456 Kosaka K (1995) Diffuse Lewy body disease. Clin Neurol 35:1455–1456
19.
go back to reference Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathology 16:32–35 Kosaka K, Iseki E, Odawara T, Yamamoto T (1996) Cerebral type of Lewy body disease. Neuropathology 16:32–35
20.
go back to reference Kosaka K, Matsushima M, Oyanagi S, Mehraein P (1980) A clinicopathological study of the "Lewy body disease". Psychiatr Neurol Jpn 82:292–311 Kosaka K, Matsushima M, Oyanagi S, Mehraein P (1980) A clinicopathological study of the "Lewy body disease". Psychiatr Neurol Jpn 82:292–311
21.
go back to reference Mann DMA, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 9:3–19PubMed Mann DMA, Yates PO (1983) Pathological basis for neurotransmitter changes in Parkinson's disease. Neuropathol Appl Neurobiol 9:3–19PubMed
22.
go back to reference McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen ENH, Ballard C, Vos RA de, Wilcock GK, Jellinger KA, Perry RH (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47:1113–1124PubMed
23.
go back to reference Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L, participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part Ⅱ. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L, participating CERAD neuropathologists (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part Ⅱ. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479–486PubMed
24.
go back to reference Morris CM, Candy JM, Bloxham CA, Edwardson JA (1992) Immunocytochemical localization of transferrin in the human brain. Acta Anat (Basel) 143:14–18 Morris CM, Candy JM, Bloxham CA, Edwardson JA (1992) Immunocytochemical localization of transferrin in the human brain. Acta Anat (Basel) 143:14–18
25.
go back to reference Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37:3200–317 Murray AM, Weihmueller FB, Marshall JF, Hurtig HI, Gottleib GL, Joyce JN (1995) Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism. Ann Neurol 37:3200–317
26.
go back to reference Pearson J, Goldstein M, Markey K, Brandeis L (1983) Human brain stem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3–32PubMed Pearson J, Goldstein M, Markey K, Brandeis L (1983) Human brain stem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase. Neuroscience 8:3–32PubMed
27.
go back to reference Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. Clin Neuropathol 19:163–169PubMed Piao YS, Wakabayashi K, Hayashi S, Yoshimoto M, Takahashi H (2000) Aggregation of α-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. Clin Neuropathol 19:163–169PubMed
28.
go back to reference Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Hasegawa M, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840PubMed Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Hasegawa M, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:839–840PubMed
29.
go back to reference Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMed Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M (1998) α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci USA 95:6469–6473CrossRefPubMed
30.
go back to reference Terada S, Ishizu H, Haraguchi T, Takehisa S, Tanabe Y, Kawai K, Kuroda S (2000) tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 100:464-468PubMed Terada S, Ishizu H, Haraguchi T, Takehisa S, Tanabe Y, Kawai K, Kuroda S (2000) tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies. Acta Neuropathol 100:464-468PubMed
31.
go back to reference Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM-Y (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44:415–422PubMed Tu PH, Galvin JE, Baba M, Giasson B, Tomita T, Leight S, Nakajo S, Iwatsubo T, Trojanowski JQ, Lee VM-Y (1998) Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein. Ann Neurol 44:415–422PubMed
32.
go back to reference Wakabayashi K, Takahashi H (1996) Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain. Neurosci Lett 217:133–136CrossRefPubMed Wakabayashi K, Takahashi H (1996) Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain. Neurosci Lett 217:133–136CrossRefPubMed
33.
go back to reference Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14–20PubMed Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H (2000) NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol 99:14–20PubMed
Metadata
Title
Clinical and neuropathological correlates of Lewy body disease
Authors
Nozomi Hishikawa
Yoshio Hashizume
Mari Yoshida
Gen Sobue
Publication date
01-04-2003
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 4/2003
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-002-0651-4

Other articles of this Issue 4/2003

Acta Neuropathologica 4/2003 Go to the issue